Hepatitis B and C in Pregnancy and Children: A Canadian Perspective

In 2016, the World Health Organization released a plan to eliminate viral hepatitis as a public health threat by 2030. For Canada to achieve the recommended decreases in HBV- and HCV-related new diagnoses and deaths, an increase in services is urgently required. Identifying those at risk of, or who have acquired HBV and HCV, remains a challenge, especially with the emergence of new priority populations such as pregnant persons and children. Importantly, prenatal, and pediatric care are times when individuals are often already engaged with the healthcare system, leading to the potential for opportunistic or co-localized care and interventions. At present, Canada may not be maximizing all available virologic tools that could lead to increases in prevention, identification, improved management, or even cure. Here, we describe the continuum of care that includes preconception, prenatal, postpartum, and pediatric stages; and identify current global and Canadian recommendations, findings, and opportunities for improvement.

[1]  E. Olsen,et al.  Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy , 2022, Obstetrics and gynecology.

[2]  S. Zheng,et al.  Clinical characteristics of hepatitis flares during pregnancy and postpartum in Chinese chronic hepatitis B virus carriers—a prospective cohort study of 417 cases , 2022, Frontiers in Immunology.

[3]  D. Dieterich,et al.  Treatment of women with hepatitis C diagnosed in pregnancy: a co-located treatment approach. , 2022, Gastroenterology.

[4]  J. Ward,et al.  Hepatitis C in pregnancy and the TiP-HepC registry. , 2022, The lancet. Gastroenterology & hepatology.

[5]  N. Terrault,et al.  Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission. , 2022, Journal of hepatology.

[6]  L. Allen,et al.  Postpartum Follow-up Care for Pregnant Persons With Opioid Use Disorder and Hepatitis C Virus Infection , 2022, Obstetrics and gynecology.

[7]  S. Vento,et al.  Chronic liver diseases must be reduced worldwide: it is time to act. , 2022, The Lancet. Global health.

[8]  H. Barkema,et al.  Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[9]  F. Faiola,et al.  Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System , 2022, Frontiers in Pharmacology.

[10]  A. Bitnun The management of infants, children, and youth at risk for hepatitis C virus infection. , 2021, Paediatrics & child health.

[11]  C. Elwood,et al.  Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study , 2021, BMC Women's Health.

[12]  P. Rosenthal,et al.  Chronic Hepatitis Is Common and Often Untreated Among Children With Hepatitis B Infection in the United States and Canada. , 2021, The Journal of pediatrics.

[13]  J. Owen,et al.  Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care , 2021, American Journal of Perinatology.

[14]  T. To,et al.  Prevalence of Prenatal Opioid Exposure in Ontario, Canada, 2014-2019 , 2021, JAMA network open.

[15]  N. Janjua,et al.  Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019 , 2020, PloS one.

[16]  Tatyana Kushner,et al.  Changing epidemiology, implications, and recommendations for Hepatitis C in Women of Childbearing Age and During Pregnancy. , 2020, Journal of hepatology.

[17]  Steven R. Martin,et al.  Real‐world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate‐treated chronic hepatitis B pregnant patients in North America , 2020, Alimentary pharmacology & therapeutics.

[18]  B. Sander,et al.  Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive study , 2020, Canadian Medical Association Journal.

[19]  N. Terrault,et al.  Viral hepatitis and pregnancy , 2020, Nature Reviews Gastroenterology & Hepatology.

[20]  P. Austin,et al.  Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time , 2020, Hepatology.

[21]  R. Kullar,et al.  Estimating paediatric hepatitis C prevalence in the United States , 2020, Journal of viral hepatitis.

[22]  R. Chou,et al.  Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. , 2020, The Lancet. Infectious diseases.

[23]  Shiliang Liu,et al.  Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus , 2020, Scientific Reports.

[24]  M. Houghton,et al.  Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs. , 2020, Canadian liver journal.

[25]  L. Meyn,et al.  Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study , 2020, The Lancet. Microbe.

[26]  C. de Martel,et al.  The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis , 2020, Journal of hepatology.

[27]  Stephen R. Spriggs,et al.  CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[28]  P. Rosenthal,et al.  Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada. , 2020, Journal of pediatric gastroenterology and nutrition.

[29]  C. Cooper,et al.  An evaluation of knowledge and concerns in women of child-bearing potential living with chronic hepatitis C infection. , 2020, Canadian liver journal.

[30]  M. Mhanna,et al.  Maternal risk factors associated with inadequate testing and loss to follow-up in infants with perinatal hepatitis C virus exposure. , 2020, Journal of neonatal-perinatal medicine.

[31]  S. Plitt,et al.  Overview of a Provincial Prenatal Communicable Disease Screening Program: 2002-2016. , 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[32]  R. Schreiber,et al.  Stability of hepatitis B viral load during pregnancy and implications for antepartum prophylaxis: A prospective cohort study. , 2019, Canadian liver journal.

[33]  Lisa P. Barrett,et al.  Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network. , 2019, CMAJ open.

[34]  S. Belle,et al.  Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study , 2019, The American journal of gastroenterology.

[35]  C. Elwood,et al.  Preventing vertical transmission of HCV in Canada , 2019, Canadian Medical Association Journal.

[36]  A. Macpherson,et al.  Factors associated with the timing of the first prenatal ultrasound in Canada , 2019, BMC Pregnancy and Childbirth.

[37]  N. Terrault,et al.  Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care , 2018, Hepatology communications.

[38]  Steven R. Martin,et al.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. , 2018, Canadian liver journal.

[39]  Hong‐Lin Chen,et al.  Prevention strategy for father-to-child transmission of hepatitis B virus: a systematic review and meta-analysis , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[40]  P. Tien,et al.  Evaluating Women’s Preferences for Hepatitis C Treatment During Pregnancy , 2018, Hepatology communications.

[41]  W. H. Pearse,et al.  American College of Obstetricians and Gynecologists , 2018, Definitions.

[42]  Noele P. Nelson,et al.  Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B , 2018, The New England journal of medicine.

[43]  A. Gruslin,et al.  No. 96-The Reproductive Care of Women Living With Hepatitis C Infection. , 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[44]  J. Dorais,et al.  Reproductive considerations in the setting of chronic viral illness , 2017, American journal of obstetrics and gynecology.

[45]  W. Balistreri,et al.  Hepatitis C virus infection in children and adolescents , 2017, Hepatology communications.

[46]  K. Murphy,et al.  No. 342-Hepatitis B and Pregnancy. , 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[47]  K. Lajkosz,et al.  Infants Born to Opioid-Dependent Women in Ontario, 2002-2014. , 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[48]  M. Guarino,et al.  Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. , 2017, Journal of hepatology.

[49]  Justin T. Maxwell,et al.  Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011-2014. , 2016, MMWR. Morbidity and mortality weekly report.

[50]  Lisa P. Barrett,et al.  CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment , 2016, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[51]  Shuqin Zhang,et al.  Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. , 2016, The New England journal of medicine.

[52]  H. Tamim,et al.  Inadequate prenatal care use among Canadian mothers: findings from the Maternity Experiences Survey , 2016, Journal of Perinatology.

[53]  C. Coffin,et al.  Clinical course of 161 untreated and tenofovir‐treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region , 2016, Journal of viral hepatitis.

[54]  F. Luciani,et al.  Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations , 2014, Journal of viral hepatitis.

[55]  C. Yeung,et al.  Vertical transmission of hepatitis C virus: Current knowledge and perspectives. , 2014, World journal of hepatology.

[56]  L. Abu-Raddad,et al.  Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  S. Locarnini,et al.  Anti‐viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post‐partum flare , 2014, Alimentary pharmacology & therapeutics.

[58]  M. Kahan,et al.  Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study. , 2013, Canadian family physician Medecin de famille canadien.

[59]  M. Krahn,et al.  Disease burden of chronic hepatitis B among immigrants in Canada. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[60]  Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. , 2013, Fertility and sterility.

[61]  H. Cai,et al.  Safety of lamivudine treatment for chronic hepatitis B in early pregnancy. , 2012, World journal of gastroenterology.

[62]  J. Preiksaitis,et al.  Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants , 2011, Journal of viral hepatitis.

[63]  E. Wagner,et al.  Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods. , 2011, Canadian journal of public health = Revue canadienne de sante publique.

[64]  E. Wagner,et al.  Hepatitis C Infection Among Pregnant Women in British Columbia: Reported Prevalence and Critical Appraisal of Current Prenatal Screening Methods , 2011 .

[65]  C. McDermott,et al.  The effectiveness of screening for hepatitis C in pregnancy. , 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[66]  Hung‐Chih Yang,et al.  Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study , 2009, Journal of viral hepatitis.

[67]  P. Stubblefield,et al.  The clinical content of preconception care: infectious diseases in preconception care. , 2008, American journal of obstetrics and gynecology.

[68]  J. Brok,et al.  Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis , 2006, BMJ : British Medical Journal.

[69]  G. Cilla,et al.  Maternal-infant transmission of hepatitis C virus infection. , 1992, The Pediatric infectious disease journal.

[70]  Canadian Immunization Guide. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.